Daejeon, South Korea

Soon-Hong Yuk

USPTO Granted Patents = 1 



Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 58(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):

Title: The Innovative Contributions of Soon-Hong Yuk

Introduction

Soon-Hong Yuk is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical compositions, particularly in the solubilization of paclitaxel. His work is characterized by a focus on enhancing the bioavailability of this important chemotherapeutic agent.

Latest Patents

Soon-Hong Yuk holds a patent for a composition aimed at the solubilization of paclitaxel. The patent describes a composition that includes 4 to 90% by weight of at least one monoglyceride, 0.01 to 90% by weight of at least one oil, and 0.01 to 20% by weight of paclitaxel. This innovative composition is designed to effectively deliver paclitaxel, ensuring it does not form aggregates when dispersed in water and adheres well to the intestinal wall, thereby enhancing its bioavailability.

Career Highlights

He is currently associated with Daehwa Pharm. Co., Ltd., where he continues to develop and refine pharmaceutical formulations. His expertise in this area has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Soon-Hong Yuk has collaborated with notable colleagues, including Hesson Chung and Seo-Young Jeong, to advance research and development in pharmaceutical compositions.

Conclusion

Soon-Hong Yuk's innovative work in the solubilization of paclitaxel represents a significant advancement in drug delivery systems. His contributions are vital for improving the efficacy of cancer treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…